HealthInvest Partners’s Morphic Holding, Inc. Common Stock MORF Stock Holding History

HealthInvest Partners’s Portfolio MORF Stock Details MORF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-20,199	Closed	-$688K	–	41
2024 Q2	$688K	Buy	20,199 +5,247	+35%	+$155K	0.42%	34
2024 Q1	$526K	Hold	14,952	–	–	0.32%	43
2023 Q4	$432K	Buy	+14,952	New	+$356K	0.34%	43

Other funds holding MORF

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Hoey Investments Coatesville, Pennsylvania $774M AUM 27.34% 1-Year Est. Return

HealthInvest Partners's MORF Position: Q3 2024 in Review

HealthInvest Partners sold out of Morphic Holding, Inc. Common Stock (MORF) in Q3 2024, closing a stake of 20,199 shares — an estimated $688K sold.

HealthInvest Partners first reported a position in MORF in Q4 2023 and held it in 3 quarters. The position peaked at $688K in Q2 2024. 2 funds tracked by Wall St. Rank hold MORF as of Q3 2024.

HealthInvest Partners reported no remaining Morphic Holding, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
HealthInvest Partners sold 20,199 Morphic Holding, Inc. Common Stock shares in Q3 2024, an estimated $688K.
HealthInvest Partners first reported a position in Morphic Holding, Inc. Common Stock in Q4 2023 and held it in 3 quarters.
HealthInvest Partners's Morphic Holding, Inc. Common Stock position peaked at $688K in Q2 2024.
2 funds tracked by Wall St. Rank held Morphic Holding, Inc. Common Stock as of Q3 2024.

Based on HealthInvest Partners's 13F filing for Q3 2024, filed 12 Nov 2024.